Cellular Biology |
From the Departments of Surgery (J.A.T., M.G.H., J.M.W., R.L.G.) and Pathology, Section on Comparative Medicine (W.D.W., R.L.G.), Wake Forest University School of Medicine, Winston-Salem, NC.
Correspondence to Randolph L. Geary, MD, FACS, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157. E-mail rgeary{at}wfubmc.edu
AbstractRemodeling
contributes to restenosis when cells shrink the artery wall at sites of
injury. This may be analogous to wound healing, where tissue remodeling
achieves wound contraction. Hyaluronan (HA) is prominent in wound
matrix and inhibits fetal scarring. HA is also produced in the artery
wall after angioplasty, where it may inhibit constrictive remodeling.
This hypothesis was tested in vitro using a model of matrix
contraction. Primate aortic smooth muscle cells and adventitial
fibroblasts were seeded into collagen I gels containing increasing
amounts of HA (0% to 50%, wt/wt). Both cell types reduced the
diameter of collagen alone
65% at 18 hours. HA significantly
increased gel contraction (diameter in mm: 0% HA, 7.7±0.9; 2%,
7.1±0.7; 10%, 6.7±0.5; 50%, 5.6±0.9;
P<0.05 for
10%), cell
spreading and telopodia, and pericellular accumulation of collagen
fibrils. These effects were mediated in part by cellular HA binding,
because an antibody against CD44 receptors blocked pericellular
collagen accumulation and enhanced gel contraction without altering
cell shape. The role of CD44 was specific, because inhibiting receptor
for hyaluronic acidmediated motility (RHAMM) had no effect. Blocking
ß1-integrins completely inhibited contraction
of collagen, but gels containing HA required CD44 and
ß1-integrin blockade for complete inhibition.
Enhanced collagen reorganization and contraction were not attributable
to increased collagenase activity, because the metalloproteinase
inhibitor batimastat had no effect. In summary, HA enhanced collagen
reorganization by the cell types most likely to mediate constrictive
remodeling after angioplasty. These effects were CD44-dependent, thus
providing a potential target for therapies to prevent constrictive
remodeling and
restenosis.
Key Words: hyaluronan smooth muscle cells adventitial fibroblasts restenosis remodeling
This article has been cited by other articles:
![]() |
A. Margulis, K. H. Nocka, A. M. Brennan, B. Deng, M. Fleming, S. J. Goldman, and M. T. Kasaian Mast Cell-Dependent Contraction of Human Airway Smooth Muscle Cell-Containing Collagen Gels: Influence of Cytokines, Matrix Metalloproteases, and Serine Proteases J. Immunol., August 1, 2009; 183(3): 1739 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tolg, S. R. Hamilton, K.-A. Nakrieko, F. Kooshesh, P. Walton, J. B. McCarthy, M. J. Bissell, and E. A. Turley Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair J. Cell Biol., December 18, 2006; 175(6): 1017 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Goueffic, C. Guilluy, P. Guerin, P. Patra, P. Pacaud, and G. Loirand Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation Cardiovasc Res, November 1, 2006; 72(2): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Franco, B. Ho, D. Mulholland, G. Hou, M. Islam, K. Donaldson, and M. P. Bendeck Doxycycline Alters Vascular Smooth Muscle Cell Adhesion, Migration, and Reorganization of Fibrillar Collagen Matrices Am. J. Pathol., May 1, 2006; 168(5): 1697 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Defawe, R. D. Kenagy, C. Choi, S. Y.C. Wan, C. Deroanne, B. Nusgens, N. Sakalihasan, A. Colige, and A. W. Clowes MMP-9 regulates both positively and negatively collagen gel contraction: A nonproteolytic function of MMP-9 Cardiovasc Res, May 1, 2005; 66(2): 402 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chai, Q. Chai, C. C. Danielsen, P. Hjorth, J. R. Nyengaard, T. Ledet, Y. Yamaguchi, L. M. Rasmussen, and L. Wogensen Overexpression of Hyaluronan in the Tunica Media Promotes the Development of Atherosclerosis Circ. Res., March 18, 2005; 96(5): 583 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Wight and M. J. Merrilees Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican Circ. Res., May 14, 2004; 94(9): 1158 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Whatling, W. McPheat, and E. Hurt-Camejo Matrix Management: Assigning Different Roles for MMP-2 and MMP-9 in Vascular Remodeling Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 10 - 11. [Full Text] [PDF] |
||||
![]() |
H. Jarvelainen, R. B. Vernon, M. D. Gooden, A. Francki, S. Lara, P. Y. Johnson, M. G. Kinsella, E. H. Sage, and T. N. Wight Overexpression of Decorin by Rat Arterial Smooth Muscle Cells Enhances Contraction of Type I Collagen In Vitro Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-M. o Chung, H. K. Gold, S. M. Schwartz, Y. Ikari, M. A. Reidy, and T. N. Wight Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2072 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Toole, T. N. Wight, and M. I. Tammi Hyaluronan-Cell Interactions in Cancer and Vascular Disease J. Biol. Chem., February 8, 2002; 277(7): 4593 - 4596. [Full Text] [PDF] |
||||
![]() |
S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni, and P. Pauletto Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant Circ. Res., December 7, 2001; 89(12): 1111 - 1121. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |